We are analyzing https://link.springer.com/article/10.1007/s10555-009-9198-3.

Title:
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer | Cancer and Metastasis Reviews
Description:
The phosphatidylinositol 3-kinase (PI3K) pathway is a critical signal transduction pathway that regulates multiple cellular functions. Aberrant activation of this pathway has been identified in a wide range of cancers. Several pathway components including AKT, PI3K and mTOR represent potential therapeutic targets and many small molecule inhibitors are in development or early clinical trials. The complex regulation of the pathway, together with the multiple mechanisms by which it can be activated, make this a highly challenging pathway to target. For successful inhibition, detailed molecular information on individual tumours will be required and it is already clear that different tumour types show distinct combinations of alterations. Recent results have identified alterations in pathway components PIK3CA, PTEN, AKT1 and TSC1 in bladder cancer, some of which are significantly related to tumour phenotype and clinical behaviour. Co-existence of alterations to several PI3K pathway genes in some bladder tumours indicates that these proteins may have functions that are not related solely to the known canonical pathway.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, google, scholar, pathway, pubmed, article, cas, bladder, mutations, pten, tsc, mutation, tumours, cell, pik, akt, tumour, expression, protein, activation, kinase, gene, journal, human, pikca, ras, found, inhibitors, development, research, mtor, complex, alterations, carcinoma, knowles, molecular, identified, genes, fig, erbb, invasive, signalling, studies, activity, tuberous, sclerosis, oncogene, cancers, urothelial, clinical,

Topics {✒️}

growth-factor signalling adenovirus-delivered cre recombinase epidermal growth factor birt-hogg-dubé syndrome birt-hogg-dube syndrome article download pdf regulates mtor signaling growth factor withdrawal bladder carcinogen butyl-n receptor tyrosine kinases muscle-invasive urothelial carcinoma pkbalpha/akt1 acts downstream muscle-invasive bladder cancer class ia p110 um-uc3 cell lines deliver wild-type akt1 tsc1-null urothelial cells erk-mediated negative regulation human lkb1/stk11 gene uk/genetics/cgp/cosmic/ high-grade papillary tumours tumor suppressor loci c-erbb-2 gene product constitutive downstream signalling gtpase-activating protein complex control mtor signaling combined pi3k-mtor inhibition akt signaling pathway targeting pi3k signalling dual pi3k-mtor inhibitors low-grade papillary tumours individual tumour-specific information open access privacy choices/manage cookies bmc research notes transitional cell carcinoma transitional-cell carcinoma regulates mtor activity bmc medical genetic tumour suppressor loci array-based cgh analysis increased cell size individualised targeted therapy metastasis reviews aims rieger-christ tumour-suppressor gene pi3k pathway-targeted agents urothelial cell carcinoma dominant negative akt nature reviews cancer

Questions {❓}

Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
         description:The phosphatidylinositol 3-kinase (PI3K) pathway is a critical signal transduction pathway that regulates multiple cellular functions. Aberrant activation of this pathway has been identified in a wide range of cancers. Several pathway components including AKT, PI3K and mTOR represent potential therapeutic targets and many small molecule inhibitors are in development or early clinical trials. The complex regulation of the pathway, together with the multiple mechanisms by which it can be activated, make this a highly challenging pathway to target. For successful inhibition, detailed molecular information on individual tumours will be required and it is already clear that different tumour types show distinct combinations of alterations. Recent results have identified alterations in pathway components PIK3CA, PTEN, AKT1 and TSC1 in bladder cancer, some of which are significantly related to tumour phenotype and clinical behaviour. Co-existence of alterations to several PI3K pathway genes in some bladder tumours indicates that these proteins may have functions that are not related solely to the known canonical pathway.
         datePublished:2009-12-16T00:00:00Z
         dateModified:2009-12-16T00:00:00Z
         pageStart:305
         pageEnd:316
         license:https://creativecommons.org/licenses/by-nc/2.0
         sameAs:https://doi.org/10.1007/s10555-009-9198-3
         keywords:
            Bladder cancer
            PI3K pathway
            PTEN
            PIK3CA
            AKT1
            TSC1
            Cancer Research
            Oncology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig7_HTML.gif
         isPartOf:
            name:Cancer and Metastasis Reviews
            issn:
               1573-7233
               0167-7659
            volumeNumber:28
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Margaret A. Knowles
               affiliation:
                     name:St James’s University Hospital
                     address:
                        name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Fiona M. Platt
               affiliation:
                     name:St James’s University Hospital
                     address:
                        name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rebecca L. Ross
               affiliation:
                     name:St James’s University Hospital
                     address:
                        name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carolyn D. Hurst
               affiliation:
                     name:St James’s University Hospital
                     address:
                        name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
      description:The phosphatidylinositol 3-kinase (PI3K) pathway is a critical signal transduction pathway that regulates multiple cellular functions. Aberrant activation of this pathway has been identified in a wide range of cancers. Several pathway components including AKT, PI3K and mTOR represent potential therapeutic targets and many small molecule inhibitors are in development or early clinical trials. The complex regulation of the pathway, together with the multiple mechanisms by which it can be activated, make this a highly challenging pathway to target. For successful inhibition, detailed molecular information on individual tumours will be required and it is already clear that different tumour types show distinct combinations of alterations. Recent results have identified alterations in pathway components PIK3CA, PTEN, AKT1 and TSC1 in bladder cancer, some of which are significantly related to tumour phenotype and clinical behaviour. Co-existence of alterations to several PI3K pathway genes in some bladder tumours indicates that these proteins may have functions that are not related solely to the known canonical pathway.
      datePublished:2009-12-16T00:00:00Z
      dateModified:2009-12-16T00:00:00Z
      pageStart:305
      pageEnd:316
      license:https://creativecommons.org/licenses/by-nc/2.0
      sameAs:https://doi.org/10.1007/s10555-009-9198-3
      keywords:
         Bladder cancer
         PI3K pathway
         PTEN
         PIK3CA
         AKT1
         TSC1
         Cancer Research
         Oncology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-009-9198-3/MediaObjects/10555_2009_9198_Fig7_HTML.gif
      isPartOf:
         name:Cancer and Metastasis Reviews
         issn:
            1573-7233
            0167-7659
         volumeNumber:28
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Margaret A. Knowles
            affiliation:
                  name:St James’s University Hospital
                  address:
                     name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Fiona M. Platt
            affiliation:
                  name:St James’s University Hospital
                  address:
                     name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rebecca L. Ross
            affiliation:
                  name:St James’s University Hospital
                  address:
                     name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carolyn D. Hurst
            affiliation:
                  name:St James’s University Hospital
                  address:
                     name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer and Metastasis Reviews
      issn:
         1573-7233
         0167-7659
      volumeNumber:28
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:St James’s University Hospital
      address:
         name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
         type:PostalAddress
      name:St James’s University Hospital
      address:
         name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
         type:PostalAddress
      name:St James’s University Hospital
      address:
         name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
         type:PostalAddress
      name:St James’s University Hospital
      address:
         name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Margaret A. Knowles
      affiliation:
            name:St James’s University Hospital
            address:
               name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Fiona M. Platt
      affiliation:
            name:St James’s University Hospital
            address:
               name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
               type:PostalAddress
            type:Organization
      name:Rebecca L. Ross
      affiliation:
            name:St James’s University Hospital
            address:
               name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
               type:PostalAddress
            type:Organization
      name:Carolyn D. Hurst
      affiliation:
            name:St James’s University Hospital
            address:
               name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
      name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
      name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK
      name:Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James’s University Hospital, Leeds, UK

External Links {🔗}(257)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.25s.

LINK . SPRINGER . COM {}